Thomas Wessel
2015
In 2015, Thomas Wessel earned a total compensation of $1.7M as Chief Medical Officer at Flex Pharma, a 2,782% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,100 |
|---|---|
| Option Awards | $1,158,266 |
| Salary | $395,000 |
| Other | $13,182 |
| Total | $1,716,548 |
Wessel received $1.2M in option awards, accounting for 67% of the total pay in 2015.
Wessel also received $150.1K in non-equity incentive plan, $395K in salary and $13.2K in other compensation.
Rankings
In 2015, Thomas Wessel's compensation ranked 5,350th out of 13,638 executives tracked by ExecPay. In other words, Wessel earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,350 out of 13,638 | 61st |
Division Manufacturing | 1,981 out of 5,187 | 62nd |
Major group Chemicals And Allied Products | 718 out of 1,857 | 61st |
Industry group Drugs | 571 out of 1,531 | 63rd |
Industry Pharmaceutical Preparations | 448 out of 1,179 | 62nd |
Source: SEC filing on April 19, 2017.
Wessel's colleagues
We found two more compensation records of executives who worked with Thomas Wessel at Flex Pharma in 2015.